본문으로 바로가기
현재 위치:
진료안내
진료과
의료진 소개
카카오 프린트

의료진 소개

이홍기 의사
이홍기 [ 종양혈액내과, 혈액암센터, 조혈모세포이식클리닉 ]

백혈병, 악성림프종, 다발성골수종, 빈혈, 혈전증, 조혈모세포이식

고맙습니다 진료예약
외래진료 외래진료 특수클리닉 특수클리닉
진료일정 05
진료일정(날짜, 오전, 오후)
날짜
오전
오후

논문

논문
  • Lee MH. Radioimmunotherapy with 131I-rituximab for patients with relapsed or refractory follicular or mantle cell lymphoma.  Asia-Pacific Journal of Clinical Oncology. 2023 Dec;19(6):690-6. 
  • Lee MH. Comparison of first-line treatment with CHOP versus ICED in patients with peripheral T-cell lymphoma eligible for upfront autologous stem cell transplantation.  Frontiers in Oncology. 2023 Aug 22;13:1230629. 
  • Lee MH. Efficacy of Antiviral Prophylaxis up to 6 or 12 Months From Completion of Rituximab in Resolved Hepatitis B Patients: A Multicenter, Randomized Study.  Journal of Korean Medical Science. 2023 Jul 17;38(28):e216. 
  • Lee MH. Oral HDAC inhibitor tucidinostat in patients with relapsed or refractory peripheral T-cell lymphoma: phase IIb results.  Haematologica. 2023 Mar;108(3):811-21. 
  • Kim H, Lee KH, Lee TH, Kim YS, Lee MH, Hur M. Clinical Impact of Recipient-Derived Isoagglutinin Levels in ABO-Incompatible Hematopoietic Stem Cell Transplantation.  Journal of Clinical Medicine. 2023 Feb;12(2):458. 
  • Lee MH. Incidence and risk factors of opportunistic infections after autologous stem cell transplantation: a nationwide, population-based cohort study in Korea.  Scientific Reports. 2023 Feb 13;13:2551. 
  • Lee MH. Busulfan, Melphalan, and Etoposide (Bume) Showed an Equivalent Effect to Busulfan, Cyclophosphamide, and Etoposide (BuCE) as Conditioning Therapy for Autologous Stem Cell Transplantation in Patients with Relapsed or High Risk Non-Hodgkin's Lymphoma: A Multicenter Randomized Phase II Study by the Consortium for Improving Survival of Lymphoma (CISL).  Cancer Research and Treatment. 2023 Jan;55(1):304-13. 
  • Lee MH. Cutaneous T-cell lymphoma in Asian patients: a multinational, multicenter, prospective registry study in Asia.  International Journal of Hematology. 2021 Sep;114(3):355-62. 
  • Lee MH. Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone.  International Journal of Hematology. 2021 Jan;113(1):81-91. 
  • Kim SY, Lee MH. Treatment outcome and prognostic factors of Korean patients with chronic lymphocytic leukemia: a multicenter retrospective study.  Korean Journal of Internal Medicine. 2021 Jan;36(1):194-204. 
  • Lee MH. Treatment with Intravenous Busulfan, Melphalan, and Etoposide (BuME) followed by Autologous Stem Cell Transplantation in Patients with Non-Hodgkin's Lymphoma: A Multicenter Study from the Consortium for Improving Survival of Lymphoma (CISL).  Transplant International. 2020 Oct;33(10):1211-9. 
  • Lee MH. Optimizing Preparative Regimen for Umbilical Cord Blood Transplantation in Adult Acute Leukemia Patients: Acute Lymphoblastic Leukemia Requires Myeloablative Conditioning but Not Acute Myeloid Leukemia.  Journal of Clinical Medicine. 2020 Jul;9(7):2310. 
  • Hong DY, Lee MH. The Inhibitory Mechanisms of Tumor PD-L1 Expression by Natural Bioactive Gallic Acid in Non-Small-Cell Lung Cancer (NSCLC) Cells.  Cancers. 2020 Mar;12(3):727. 
  • Kim H, Moon HW, Yun YM, Lee MH, Hur M. A case of reactive erythrocytosis with CD34/CD61 dual positive megakaryocytes.  International Journal of Laboratory Hematology. 2020 Feb;42(1):e17-9. 
  • Lee MH. The effectiveness and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma in real-world clinical practice: a study of the Korean Multiple Myeloma Working Party (KMMWP-151 study).  Annals of Hematology. 2020 Feb;99(2):309-19. 
  • Yoon S, Kim H, Hur M, Han SH, Chung HJ, Moon HW, Yun YM, Lee MH. Do we still need morphologic evaluation in new era of advanced minimal residual disease analyses?.  International Journal of Laboratory Hematology. 2019 Dec;41(6):e145-e147. 
  • Park M, Hur M, Yi A, Kim H, Lee MH, Jeon EY, Oh KM, Lee MH. Utility of temperature-sensitive indicators for temperature monitoring of red-blood-cell units.  Vox Sanguinis. 2019 Jul;114(5):487-494. 
  • Jung SH, Lee SR, Yang DH, Lee S, Yoon JH, Lee H, Bang SM, Koh Y, Park S, Kim DS, Yhim HY, Kim SH, Lee JH, Sohn SK, Song IC, Lee MH, Cheong JW, Choi Y, Shin HJ. Efficacy and safety of blinatumomab treatment in adult Korean patients with relapsed/refractory acute lymphoblastic leukemia on behalf of the Korean Society of Hematology ALL Working Party.  Annals of Hematology. 2019 Jan;98(1):151-158. 
  • Cheong HS, Ki HK, Kim SY, Kim JY, Lee MH. Oral mucormycosis in patients with haematologic malignancies in a bone marrow transplant unit.  Mycoses. 2017 Dec;60(12):836-41. 
  • Lee MH. Can we consider discontinuation of hypomethylating agents in patients with myelodysplastic syndrome : a retrospective study from The Korean Society of Hematology AML/MDS working party.  Oncotarget. 2017 Oct 3;8(45):79414-24. 
  • Lee MH. A prospective, open-label, multicenter, observational study to evaluate the efficacy and safety of bortezomib-melphalan-prednisone as initial treatment for autologous stem cell transplantation-ineligible patients with multiple myeloma.  Oncotarget. 2017 Jun 6;8(23):37605-18. 
  • Cho SH, Suh C, Do YR, Lee JJ, Yun HJ, Oh SY, Lee HS, Cho SG, Cho IS, Lee WS, Won YW, Kim HJ, Lee MH, Lee SI, Lim SN, Sohn BS, Ahn HJ, Chang MH, Kwon KA, Kim WS. Clinical features and survival of patients with follicular lymphoma in Korea.  Clin Lymphoma, Myeloma, Leukemia. 2016. 
  • Ahn JS, Kim YK, Min YH, Cheong JW, Jang JH, Jung CW, Kim IH, Yoon HJ, Lee HG, Sohn SK, Moon JH, Kim H, Kim YJ, Won JH, Chung JS, Mun YC, Lee JH, Kim HJ. Azacitidine pre-treatment followed by reduced-intensity stem cell transplantation in patients with higher-risk myelodysplastic syndrome.  Acta Haematologica. 2015;134:40-48. 
  • Kim HJ, Hur M, Kim H, Moon HW, Yun YM, Kim SY, Lee MH. A rare case of Waldenstrom macroglobulinemia/lymphoplasmacytic lymphoma with light chain discrepancy between B lymphocyte population and serum paraprotein.  Ann Clin Lab Sci. 2015;45:593-597. 
  • Kim SY, Kim AR, Yoon SY, Cho YH, Lee MH. Substitution of methotrexate with corticosteroids for acute graft-versus-host disease prevention in transplanted patients who develop methotrexate toxicity.  Ann Hematol. 2015;95:483-491. 
  • Park SY, Yu HM, Kim J, An SH, Kim WY, Hur M, Lee HG. Hodgkin’s lymphoma after autologous hematopoietic stem cell transplantation for angioimmunoblastic T-cell lymphoma.  Korean J Med. 2014;86:774-780. 
  • Lee HG, Choi YS, Kim SY, Kim IH, Kim YK, Kim YS, Lee HS, Kim SJ, Kim JA, Park BB, Park J, Shim H, Eom HS, Lee JL, Park SK, Cheong JW, Park KW. R-CHOP chemoimmunotherapy followed by autologous transplantation for the treatment of diffuse large B-cell lymphoma.  Blood Research. 2014;49:107-14. 
  • Yoon SY, Kim JH, Kim WS, Chung HW, Lee MH, Kim SY, Cho YH. Pleural metastasis as initial presentation of occult gastric cardia cancer: a possible role of PET-CT in diagnosis.  Cancer Res Treat. 2014;46:415-418. 
  • Kim SW, Yu HM, Lee YJ, Kim HJ, Hur M, Lee HG. Polycythemia vera presenting with generalized chorea: a case report and review of the literature.  Korean J Med. 2014;87:619-624. 
  • Kim SJ, Kang WC, Kim SW, Lee YJ, Kim WY, Kim HJ, Lee HG. Metastatic pulmonary calcification in a patient with adult T-cell leukemia/lymphoma.  Korean J Med. 2014;87:750-755. 
  • Lee HS, Kim K, Yoon DH, Kim JS, Bang SM, Lee JO, Eom HS, Lee H, Kim I, Lee WS, Bae SH, Kim SH, Lee MH, Do YR, Lee JH, Hong JS, Shin HJ, Lee JH, Mun YC, Min CK. Clinical factors associated with response of survival after chemotherapy in patients with Waldenstrom Macroglobulinemia in Korea.  BioMed Research International. 2014. 
  • Park SY, Yu HM, Kim J, An SH, Kim WY, Hur M, Lee HG. Hodgkin’s lymphoma after autologous hematopoietic stem cell transplantation for angioimmunoblastic T-cell lymphoma.  Korean J Med. 2014;86:774-780. 
  • Lee HG, Choi YS, Kim SY, Kim IH, Kim YK, Kim YS, Lee HS, Kim SJ, Kim JA, Park BB, Park J, Shim H, Eom HS, Lee JL, Park SK, Cheong JW, Park KW. R-CHOP chemoimmunotherapy followed by autologous transplantation for the treatment of diffuse large B-cell lymphoma.  Blood Research. 2014;49:107-14. 
  • Yoon SY, Kim JH, Kim WS, Chung HW, Lee MH, Kim SY, Cho YH. Pleural metastasis as initial presentation of occult gastric cardia cancer: a possible role of PET-CT in diagnosis.  Cancer Res Treat. 2014;46:415-418. 
  • Kim SW, Yu HM, Lee YJ, Kim HJ, Hur M, Lee HG. Polycythemia vera presenting with generalized chorea: a case report and review of the literature.  Korean J Med. 2014;87:619-624. 
  • Kim SJ, Kang WC, Kim SW, Lee YJ, Kim WY, Kim HJ, Lee HG. Metastatic pulmonary calcification in a patient with adult T-cell leukemia/lymphoma.  Korean J Med. 2014;87:750-755. 
  • Lee YG, Kim I, Yoon SS, Park S, Cheong JW, Min YH, Lee JO, Bang SM, Yi HG, Kim CS, Park Y, Kim BS, Mun YC, Seong CM, Lee JH, Kim SY, Lee HG, Kim YK, Kim HJ. Comparative analysis between azacitidine and decitabine for the treatment of myelodysplastic syndromes.  Br J Haematol. 2013;161:339-347. 
  • Kim K, An S, Cha HJ, Choi YM, Choi SJ, An IS, Lee HG, Min YH, Lee SJ, Bae S. Lenalidomide induces apoptosis and alters gene expression in non-small cell lung cancer cells.  Oncol Lett. 2013;5:588-592. 
  • Yi HG, Kim JS, Suh C, Kim WS, Kwak JY, Lee JS, Kim YS, Joo YD, Min YH, Lee HG, Yoon SS, Won JH, Park S, Kim HC, Kim CS. Clinical features and survival outcomes of patients with diffuse large B-cell lymphoma: analysis of web-based data from the Korean Lymphoma Working Party Registry.  Blood Reseach. 2013;48:115-120. 
  • Shin SY, Lee KS, Choi YK, Lim HJ, Lee HG, Lim Y, Lee YH. The antipsychotic agent chlorpromazine induces autophagic cell death by inhibiting the Akt/mTOR pathway in human U-87MG glioma cells.  Carcinogenesis. 2013;34:2080-2089. 
  • Kim HJ, Kim SY, Lee MH, Min WS. Peripheral blood stem cell transplantation from human leukocyte antigen-matched sibling donors and unrelated donors in acute myeloid leukemia patients.  Acta Haematol. 2013;130:206-216. 
  • Cho JH, Hur M, Moon HW, Yun YM, Ko YS, Kim WS, Lee MH. Therapy-related acute leukemia with mixed phenotype and t(9;22)(q32;q11.2): a case report and review of the literature.  Human Pathol. 2012;43:605-9. 
  • Yoon SY, K HK, Kim SY, Cho YH, Lee HG, Yoo MW. Pneumocystis carinie pneumonia in gastric cancer patients without acquired immune deficiency syndrome: 3 casese report and literature review.  J Korean Surg Soc. 2012;83:50-5. 
  • Lee MH, Park E, Lee JC, Kim SY, Kim SY, Lee SY, Cho YH, Yoon SY. Cutoff values of serum ferritin and TIBC saturation for the evaluation of gastrointestinal neoplasms in adult anemic patients.  Int J Hematol. 2012;96:214-21. 
  • Shin SY, Choi C, Lee HG, Lim Y, Lee YH. Transcriptional regulation of the interleukin-11 gene by oncogenic Ras.  Carcinogenesis. 2012;33(12):2467-76.